All pregnant women are recommended to be screened for gestational diabetes, yet many birth centers and midwifery practices rely on external laboratories that can delay results by 24 hours or more. Visit HemoCue at the 2026 AABC Birth Institute to learn how CLIA-waived, point-of-care glucose testing can help you deliver answers during the patient visit, supporting timely conversations and care decisions without the wait for off-site lab results.
Discover how the HemoCue® Glucose 201 System, FDA cleared to aid in the diagnosis of diabetes, enables gestational diabetes screening with results available in one minute. Connect with our team to discuss how birth centers and midwives can streamline workflows, reduce diagnostic delays, and spend more time focused on patient care.
Complete the form below to schedule a meeting with us at the 2026 AABC Birth Institute, October 29-November 1, 2026, at the Hilton Indianapolis Hotel & Suites.
